Colorectal cancer (CRC) is still the second most common cause of cancer death in the United States, despite the availability of a range of interventions to reduce the burden of CRC. Microsimulation modeling can inform policy makers in prioritizing among these cancer-control interventions. The CISNET-CRC team includes three collaborative modeling groups, each with a state-of-the-art, population-based microsimulation model for CRC: MISCAN, SimCRC, and CRC-SPIN. These three modeling groups have collaborated for eight years and have delivered a substantial body of policy-oriented work. We propose to continue this collaboration, further developing our models and using them to identify optimal cancer-control policies and practices to reduce the burden of CRC. Our proposed work centers around three specific aims.
In Aim 1 we extend our models to reflect the evolving understanding of the CRC disease processes and to incorporate new and updated screening modalities, allowing us to address new policy questions. Here we focus on new data on genomics, biomarkers, pathways, and the upcoming data from randomized controlled trials of flexible sigmoidoscopy screening.
In Aim 2 we apply our updated models to inform health policy, including evaluation of interventions across the cancer-control spectrum. New technologies and more individually tailored screening and treatment strategies will be evaluated with a special focus on health disparities.
In Aim 3 we disseminate results from our models to inform health policy, via methods that engage policy makers and encourage appropriate use of modeling in policy making and decision support. Here we envision innovation using open-access web-based model applications. We will begin with model extensions required for specific applications, with the balance of the work shifting heavily toward applications over the course of the funding period. Dissemination of our findings will occur throughout the funding period.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-4 (M1))
Program Officer
Stedman, Margaret R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
Lansdorp-Vogelaar, Iris; Goede, S Lucas; Bosch, Linda J W et al. (2017) Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening. Clin Gastroenterol Hepatol :
Hubbard, Rebecca A; Johnson, Eric; Chubak, Jessica et al. (2017) Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol 17:101-112
Rutter, Carolyn M; Knudsen, Amy B; Marsh, Tracey L et al. (2016) Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications. Med Decis Making 36:604-14
Meester, Reinier G S; Zauber, Ann G; Doubeni, Chyke A et al. (2016) Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol 14:1445-1451.e8
Knudsen, Amy B; Zauber, Ann G; Rutter, Carolyn M et al. (2016) Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA 315:2595-609
Haug, Ulrike; Knudsen, Amy B; Lansdorp-Vogelaar, Iris et al. (2015) Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection. Int J Cancer 136:2864-74
Meester, Reinier G S; Doubeni, Chyke A; Zauber, Ann G et al. (2015) Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer 121:2281-5
Tinmouth, Jill; Lansdorp-Vogelaar, Iris; Allison, James E (2015) Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64:1327-37
van Hees, Frank; Saini, Sameer D; Lansdorp-Vogelaar, Iris et al. (2015) Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology 149:1425-37
Zauber, Ann G (2015) The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci 60:681-91

Showing the most recent 10 out of 34 publications